Application of muscle relaxants in Germany. A survey of German anaesthesia departments;Anwendung von muskelrelaxanzien in Deutschland. Eine umfrage an Deutschen anästhesieeinrichtungen

Anaesthesist

Volumn 52, Issue 5, 2003, Pages 427-434

  Blobner, M ^a   Sohnel A M ^a   Van De Roemer, A ^f   Bachmann, H ^f   Geldner, G ^b   Hofmockel, R ^f   Fuchs Buder, T ^c   Diefenbach, C ^d   Ulm, K ^e  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f NONE

Author keywords

Germany; Muscle relaxants; Neuromuscular monitoring; Survey

Indexed keywords

MUSCLE RELAXANT AGENT;

CORRELATION ANALYSIS; DRUG MONITORING; EVALUATION; HEALTH SURVEY; HOSPITAL DEPARTMENT; HUMAN; LARYNGEAL MASK; LOGISTIC REGRESSION ANALYSIS; PRIVATE PRACTICE; QUESTIONNAIRE; REVIEW;

ANESTHESIA; ANESTHESIA DEPARTMENT, HOSPITAL; DATA COLLECTION; DRUG UTILIZATION; GERMANY; HUMANS; LARYNGEAL MASKS; LOGISTIC MODELS; MUSCLE RELAXANTS, CENTRAL; QUESTIONNAIRES;

EID: 0037600671     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-003-0500-4     Document Type: Review

References (28)

1. Barclay S, Todd C, Finlay I, Grande G, Wyatt P (2002) Not another questionnaire! Maximizing the response rate, predicting non-response and assessing non-response bias in postal questionnaire studies of GPs. Fam Pract 19:105-111
2. Brain AI (1983) The laryngeal mask - a new concept in airway management. Br J Anaesth 55:801-805
3. Buzello W, Diefenbach C, Abel M (1994) Succinylcholin: Quo vadis? Anasthesiol Intensivmed Notfallmed Schmerzther 29:70-71
4. Clerque F, Auroy Y, Pequignot F, Jougla E, Lienhart A, Laxenaire MC (1999) French survey of anesthesia in 1996. Anesthesiology 91:1509-1520
5. Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin (1995) Stellungnahme der DGAI zum Einsatz von Succinylcholin. Anaesth Intensivmed 36:31-32
6. Donaldson GW, Moinpour CM, Bush NE et al. (1999) Physician participation in research surveys. A randomized study of inducements to return mailed research questionnaires. Eval Health Prof 22:427-441
7. Fuchs-Buder T, Hofmockel R, Geldner G, Diefenbach C, Ulm K, Blobner M (2003) Einsatz des neuromuskulären Monitorings in Deutschland. Anaesthesist 52: in Druck
8. Geest JB van,Wynia MK, Cummins DS, Wilson IB (2001) Effects of different monetary incentives on the return rate of a national mail survey of physicians. Med Care 39:197-201
9. Geldner G, Diefenbach C, Fuchs-Buder T, Hofmockel R, Blobner M (2003) Anwendung von Muskelrelaxanzien zur Routineeinleitung in Deutschland. Anaesthesist 52: 435-441
10. Goudsouzian NG (2001) Rapacuronium and bronchospasm. Anesthesiology 94:727-728
11. Hofmockel R, Geldner G, Diefenbach C, Fuchs-Buder T, Blobner M (2003) Die Anwendung von Muskelrelaxanzien zur Blitzintubation in Deutschland. Anaesthesist 52: in Druck
12. Hughes R, Chapple DJ (1981 ) The pharmacology of atracurium: a new competitive neuromuscular blocking agent. Br J Anaesth 53:31-44
13. Inada Y, Ikeda K, Mori K et al. (1987) Clinical evaluation of sevoflurane - a multi-center clinical trial. Masui 36:866-874
14. Jones RM, Cashman JN, Mant TG (1990) Clinical impressions and cardiorespiratory effects of a new fluorinated inhalation anaesthetic, desflurane (1-653), in volunteers. Br J Anaesth 64:11-15
15. Konstadt SN, Reich DL, Stanley TE 3rd, DePerio M, Chuey C, Schwartzbach C, Abou Donia M (1995) A two-center comparison of the cardiovascular effects of cisatracurium (Nimbex) and vecuronium in patients with coronary artery disease. Anesth Analg 81:1010-1014
16. Kron SS (2001) Severe bronchospasm and desaturation in a child associated with rapacuronium. Anesthesiology 94:923-924
17. Lemeshow S, Hosmer DW Jr. (1982) A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115:92-106
18. Meakin GH, Pronske EH, Lerman J, Orr R, Joffe D, Savaree AM, Lynn AM (2001) Bronchospasm after rapacuronium in infants and children. Anesthesiology 94:926-927
19. Morris J, Cook TM (2001) Rapid sequence induction: a national survey of practice. Anaesthesia 56:1090-1097
20. Naguib M (2001) How serious is the bronchospasm induced by rapacuronium? Anesthesiology 94:924-925
21. Osmer C, Vogele C, Zickmann B, Hempelmann G (1996) Comparative use of muscle relaxants and their reversal in three European countries: a survey in France, Germany and Great Britain. Eur J Anaesthesiol 13:389-399
22. Payne JP, Hughes R (1981) Evaluation of atracurium in anaesthetized man. Br J Anaesth 53:45-54
23. Rosow C (1993) Remifentanil: a unique opioid analgesic. Anesthesiology 79:875-876
24. Savage DS, Sleigh T, Carlyle I (1980) The emergence of ORG NC 45, 1-[2 beta,3 alpha, 5 alpha,16 beta, 17 beta)-3, 17-bis(acetyloxy)-2-(1-piperidinyl)-androstan-16-yl]-1-methyl piperidinium bromide, from the pancuronium series. Br J Anaesth 52 [Suppl 1]:3-9
25. Savarese JJ, Kitz PJ (1975) Does clinical anesthesia need new neuromuscular blocking agents? Anesthesiology 42:236-239
26. Savarese JJ, Ali HH, Basra SJ et al. (1988) The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U): a shortacting non-depolarizing ester neuromuscular blocking drug. Anesthesiology 68:723-732
27. Suttner S, Boldt J, Piper SN, Schmidt C, Kumle B (2000) Economic aspects of different muscle relaxant regimens. Anasthesiol Intensivmed Notfallmed Schmerzther 35:300-305
28. Wierda JM, Wit AP de, Kuizenga K, Agoston S (1990) Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent. Br J Anaesth 64:521-523